Specifications Manual for Joint Commission National Quality Measures (v2026A)
Posted: 08/08/2025

Release Notes:
Appendix CTJC
Version 2026A

Appendix C
Medication Tables

Table Number 1.2: ACEIs

Medication
ACCUPRIL
ACCURETIC
ACEON
ALTACE
BENAZEPRIL
BENAZEPRIL HYDROCHLORIDE
BENAZEPRIL/AMLODIPINE
BENAZEPRIL/HYDROCHLOROTHIAZIDE
CAPOTEN
CAPOZIDE
CAPOZIDE 25/15
CAPOZIDE 25/25
CAPOZIDE 50/15
CAPOZIDE 50/25
CAPTOPRIL
CAPTOPRIL HCT
CAPTOPRIL/HYDROCHLOROTHIAZIDE
ENALAPRIL
ENALAPRIL MALEATE/HYDROCHLOROTHIAZIDE
ENALAPRIL/HYDROCHLOROTHIAZIDE
ENALAPRILAT
FOSINOPRIL
FOSINOPRIL SODIUM/HYDROCHLOROTHIAZIDE
LISINOPRIL
LISINOPRIL/HYDROCHLOROTHIAZIDE
LOTENSIN
LOTENSIN HCT
LOTREL
MAVIK
MOEXIPRIL
MOEXIPRIL HYDROCHLORIDE
MOEXIPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE
MOEXIPRIL/HYDROCHLOROTHIAZIDE
MONOPRIL
PERINDOPRIL
PERINDOPRIL ERBUMINE
PRINIVIL
PRINZIDE
QUINAPRIL
QUINAPRIL HCL
QUINAPRIL HCL/HCT
QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE
QUINAPRIL/HYDROCHLOROTHIAZIDE
QUINARETIC
RAMIPRIL
TARKA
TRANDOLAPRIL
TRANDOLAPRIL/VERAPAMIL
TRANDOLAPRIL/VERAPAMIL HYDROCHLORIDE
UNIRETIC
UNIVASC
VASERETIC
VASOTEC
ZESTORETIC
ZESTRIL

Table Number 1.7: ARBs

Medication
ATACAND
ATACAND HCT
AVALIDE
AVAPRO
AZILSARTAN
AZILSARTAN/CHLORTHALIDONE
AZOR
BENICAR
BENICAR HCT
CANDESARTAN
CANDESARTAN/HYDROCHLOROTHIAZIDE
COZAAR
DIOVAN
DIOVAN HCT
EDARBI
EDARBYCLOR
EPROSARTAN
EPROSARTAN/HYDROCHLOROTHIAZIDE
EXFORGE
HYZAAR
IRBESARTAN
IRBESARTAN/HYDROCHLOROTHIAZIDE
LOSARTAN
LOSARTAN/HYDROCHLOROTHIAZIDE
MICARDIS
MICARDIS HCT
OLMESARTAN
OLMESARTAN MEDOXOMIL
OLMESARTAN MEDOXOMIL/AMLODIPINE
OLMESARTAN/AMLODIPINE
OLMESARTAN/AMLODIPINE/HYDROCHLOROTHIAZIDE
OLMESARTAN/HYDROCHLOROTHIAZIDE
TASOSARTAN
TELMISARTAN
TELMISARTAN/AMLODIPINE
TELMISARTAN/HYDROCHLOROTHIAZIDE
TEVETEN
TEVETEN HCT
TRIBENZOR
TWYNSTA
VALSARTAN
VALSARTAN/ALISKIREN
VALSARTAN/AMLODIPINE
VALSARTAN/HYDROCHLOROTHIAZIDE
VALTURNA
VERDIA

Table Number 8.1: Statin Medications

Medication
Altoprev
Atorvastatin
Atorvastatin/amlodipine
Caduet
Crestor
Fluvastatin
Fluvastatin XL
Lescol
Lescol XL
Lipitor
Livalo
Lovastatin
Mevacor
Pitavastatin
Pravastatin
Rosuvastatin
Simvastatin
Simvastatin/ezetimibe
Vytorin
Zocor

Table Number 8.2: Antithrombotic Medications - Stroke

Medication
ASA
ASA Baby
ASA Baby Chewable
ASA Baby Coated
ASA Bayer
ASA Bayer Children's
ASA Buffered
ASA Children's
ASA EC
ASA Enteric Coated
ASA/Maalox
ASA/dipyridamole
Acetylsalicylic Acid
Acova
Acuprin 81
Alka-Seltzer
Alka-Seltzer Morning Relief
Anacin
Apixaban
Argatroban
Arixtra
Arthritis Foundation Aspirin
Arthritis Pain Ascriptin
Arthritis Pain Formula
Ascriptin
Aspir-10
Aspir-Low
Aspir-Lox
Aspir-Mox
Aspir-Trin
Aspirbuf
Aspircaf
Aspirin
Aspirin Baby
Aspirin Bayer
Aspirin Bayer Children's
Aspirin Buffered
Aspirin Child
Aspirin Child Chewable
Aspirin Children's
Aspirin EC
Aspirin Enteric Coated
Aspirin Litecoat
Aspirin Lo-Dose
Aspirin Low Strength
Aspirin Tri-Buffered
Aspirin, Extended Release
Aspirin/caffeine
Aspirtab
Bayer Aspirin
Bayer Aspirin PM Extra Strength
Bayer Children’s
Bayer EC
Bayer Enteric Coated
Bayer Low Strength
Bayer Plus
Brilinta
Buffered ASA
Buffered Aspirin
Buffered Baby ASA
Bufferin
Bufferin Arthritis Strength
Bufferin Extra Strength
Buffex
CTD Aspirin
Cama Arthritis Reliever
Child’s Aspirin
Clopidogrel
Coated Aspirin
Cosprin
Coumadin
Dabigatran
Dabigatran etexilate
Dalteparin
Dasprin
EC ASA
Easprin
Ecotrin
Ecotrin Low Strength Adult
Edoxaban
Effervescent Pain & Antacid
Eliquis
Empirin
Enoxaparin
Entab
Entaprin
Entercote
Enteric Coated Aspirin
Enteric Coated Baby Aspirin
Excedrin
Excedrin Extra Strength
Excedrin Geltab
Excedrin Migraine
Extra Strength Bayer
Fondaparinux
Fragmin
Genacote
Genprin
Halfprin
Heparin sodium I.V.
Hirudin
Jantoven
Lepirudin
Litecoat Aspirin
Lovenox
Low Dose ASA
Magnaprin
Med Aspirin
Norwich Aspirin
Pain Relief (Effervescent)
Pain Relief with Aspirin
Plavix
Pradaxa
Refludan
Rivaroxaban
Savaysa
Sloprin
St. Joseph Aspirin
Stanback Analgesic
Therapy Bayer
Ticagrelor
Ticlopidine
Tri Buffered Aspirin
Uni-As
Uni-Buff
Uni-Tren
Warfarin
Warfarin Sodium
Xarelto
Zorprin

Table Number 8.3: Anticoagulant Medications - Stroke

Medication
Acova
Apixaban
Argatroban
Arixtra
Coumadin
Dabigatran
Dabigatran etexilate
Dalteparin
Edoxaban
Eliquis
Enoxaparin
Fondaparinux
Fragmin
Heparin I.V.
Hirudin
Jantoven
Lepirudin
Lovenox
Pradaxa
Refludan
Rivaroxaban
Savaysa
Warfarin
Warfarin Sodium
Xarelto

Table Number 9.1: FDA-Approved Tobacco Cessation Medications

Medication
Bupropion (SR)
Commit Lozenge
Habitrol Patch
NTS (nicotine transdermal system, step 2 and 3)
Nicoderm CQ
Nicorette DS (double strength) gum
Nicorette gum
Nicorette lozenge
Nicotine Polacrilex
Nicotine Polacrilex gum
Nicotine Polacrilex lozenge
Nicotine Step 1
Nicotine Step 2
Nicotine Step 3
Nicotine TD
Nicotine Transdermal System
Nicotine gum
Nicotine nasal spray
Nicotrol NS
Varenicline
Wellbutrin (SR)

Table Number 9.2: FDA-Approved Medications for Alcohol and Drug Dependence

Medication
Acamprosate
Buprenorphine
Buprenorphine-Naloxone
Butrans
Belbuca
Brixadi
Disulfiram
Methadone
Methadose
Naltrexone
Sublocade
Suboxone
Vivitrol injection
Zubsolv

Appendix C
CPT® only copyright 2025 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2026A)
Discharges 01-01-26 (1Q26) through 06-30-26 (2Q26)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

CPT® only copyright 2025 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.

^